Clonz Biotech Pvt Ltd

Clonz Biotech is a specialized biopharmaceutical company based in Genome Valley, Hyderabad, India, focused exclusively on the development, manufacturing, and commercialization of biosimilar therapeutic monoclonal antibodies (MABs). Founded in 2010 by a team of industry veterans, the company provides end-to-end contract development and manufacturing services (CDMO), including cell line engineering, process development, and cGMP-compliant manufacturing. The company operates a state-of-the-art, fully integrated facility that supports the entire lifecycle of biologics, from early-stage clone development to commercial supply. Clonz Biotech is recognized for its expertise in mammalian (CHO) expression platforms and its commitment to making high-quality biosimilars and biobetters more accessible in global markets, particularly in oncology, immunology, and ophthalmology.